Publications by authors named "Kurt Oettel"

Claim this Profile
B
Biosimilar Use Among 38 ASCO PracticeNET Practices, 2019-2021.
Brian Bourbeau, Gary H Lyman, Xiudong Jennifer Lei, Lee Jones, Jon Rosenthal, Kurt R Oettel

JCO Oncol Pract· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Review of Concurrent Chemo/Radiation, Immunotherapy, Radiation Planning, and Biomarkers for Locally Advanced Non-small Cell Lung Cancer and Their Role in the Development of ECOG-ACRIN EA5181.
John Michael Varlotto, Zhuoxin Sun, Bonnie Ky, Jenica Upshaw, Thomas J Fitzgerald, Kurt Oettel

Clin Lung Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Review of Immunotherapy for Stage III and Metastatic Non-Small Cell Lung Cancer and the Rationale for the ECOG-ACRIN EA5181 Study.
John M Varlotto, Zhuoxin Sun, Bonnie Ky, Jenica Upshaw, Sharyn I Katz, Kurt Oettel

Oncologist· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benchmarks for Academic Oncology Faculty.
Lowell Anthony, George Atweh, Ravi Bhatia, Lisa A Carey, Jenny C Chang, Kurt Oettel

JCO Oncol Pract· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care.
Nathan A Pennell, Melissa Dillmon, Laura A Levit, E Allyn Moushey, Ajjai S Alva, Kurt R Oettel

J Clin Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASCO Voices 2020.
Daniel Rayson, Jose A Bufill, Julia Close, Alice Cyusa, Kurt Oettel

J Clin Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide and dexamethasone in patients with relapsed multiple myeloma and impaired renal function: PrE1003, a PrECOG study.
Joseph Mikhael, Judith Manola, Amylou C Dueck, Suzanne Hayman, Kurt Oettel

Blood Cancer J· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cetuximab plus carboplatin and paclitaxel with or without bevacizumab versus carboplatin and paclitaxel with or without bevacizumab in advanced NSCLC (SWOG S0819): a randomised, phase 3 study.
Roy S Herbst, Mary W Redman, Edward S Kim, Thomas J Semrad, Lyudmila Bazhenova, Kurt Oettel

Lancet Oncol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are We on the Same Page? Patient and Provider Perceptions About Exercise in Cancer Care: A Focus Group Study.
Agnes Smaradottir, Angela L Smith, Andrew J Borgert, Kurt R Oettel

J Natl Compr Canc Netw· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vorinostat and bortezomib as third-line therapy in patients with advanced non-small cell lung cancer: a Wisconsin Oncology Network Phase II study.
Tien Hoang, Toby C Campbell, Chong Zhang, Kyungmann Kim, Jill M Kolesar, Kurt R Oettel

Invest New Drugs· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of sorafenib, oxaliplatin and 2 days of high dose capecitabine in advanced pancreatic and biliary tract cancer: a Wisconsin oncology network study.
Noelle K LoConte, Kyle D Holen, William R Schelman, Daniel L Mulkerin, Dustin A Deming, Kurt Oettel

Invest New Drugs· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nuclear EGFR protein expression predicts poor survival in early stage non-small cell lung cancer.
Anne M Traynor, Tracey L Weigel, Kurt R Oettel, David T Yang, Chong Zhang

Lung Cancer· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II study of vinorelbine and exisulind as first-line treatment of advanced non-small cell lung cancer in patients at least 70 years old: a wisconsin oncology network study.
Steven Attia, Anne M Traynor, Kyungmann Kim, Joseph J Merchant, Tien Hoang, Kurt R Oettel

J Thorac Oncol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of medical castration on CYP3A4 enzyme activity using the erythromycin breath test.
Paul R Hutson, Kurt Oettel, Jeff Douglas, Mark Ritter, Ed Messing

Cancer Chemother Pharmacol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A morphealike skin condition caused by Borrelia burgdorferi in an immunocompromised patient.
Jeffrey S Sartin, Kurt R Oettel

Mayo Clin Proc· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of interferon-alpha and doxycycline for advanced renal cell carcinoma.
Michael Huie, Kurt Oettel, Lynn Van Ummersen, Kyung Mann Kim, Yulin Zhang

Invest New Drugs· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II study of gemcitabine and exisulind as second-line therapy in patients with advanced non-small cell lung cancer.
Tien Hoang, KyungMann Kim, Joseph Merchant, Anne M Traynor, James McGovern, Kurt R Oettel

J Thorac Oncol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of perillyl alcohol (NSC 641066) administered daily in patients with metastatic androgen independent prostate cancer.
Glenn Liu, Kurt Oettel, Howard Bailey, Lynn Van Ummersen, Kendra Tutsch

Invest New Drugs· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of 1alpha-hydroxyvitamin d(2) in patients with hormone refractory prostate cancer.
Glenn Liu, Kurt Oettel, Gregory Ripple, Mary Jane Staab, Dorothea Horvath

Clin Cancer Res· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis